Bifogade filer
Warrants of series TO6 were subscribed to approximately 94 percent and Lumito receives approximately SEK 12.6 million
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Lumito AB (publ) ("Lumito" or the "Company") today announces the outcome of the exercise of warrants of series TO6, which were issued in connection to an issue and loan financing during the fourth quarter of 2023. In total, 32,206,770 warrants were exercised, corresponding to approximately 94 percent of the total number of outstanding warrants, for subscription of 32,206,770 shares at a subscription price of SEK 0.39 per share. Through the exercise of the warrants Lumito will receive approximately SEK 12.6 million before issuing costs.
Background
The exercise period for the warrants of series TO6 ran during the period from and including November 4, 2024, to and including November 15, 2024. The subscription price per share upon exercise of the warrants of series TO6 was set at 0.39 SEK.
“I am honored and grateful for the great interest shown by our shareholders. Being a new CEO, this truly means a lot. We are in an exciting phase where perseverance is important. We have a great product that meets unmet needs. We will with continued high focus interact and collaborate with users and potential customers to attach key opinion leaders, and to start generating revenue to Lumito”, Sanna Wallenborg, Lumito CEO.
Exercised warrants have been replaced with interim shares (IA), pending registration with the Swedish Companies Registration Office. The interim shares are expected to be converted to shares within approximately three (3) weeks.
Shares, share capital and dilution
Through the exercise of the warrants, the number of shares in Lumito increases by 32,206,770 shares, from 233,691,423 shares to a total of 265,898,193 shares. The share capital will increase by SEK 805,169.25 from SEK 5,842,285.58 to SEK 6,647,454.83. For existing shareholders who did not exercise any warrants, the dilution amounts to approximately 12.1 percent of the number of shares and votes in the Company.
Advisers
Mangold Fondkommission AB is financial adviser and Advokatfirman Lindahl KB is legal advisor to Lumito in connection with the exercise of the warrants of series TO6.